Fábio Cardoso Cruz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fábio Cardoso Cruz has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
A. Anjos-Santos
Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil
2 shared publicationsB.T. Rodolpho
Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil
2 shared publications- Cristiane Aparecida Favoretto
Laboratory of Molecular and Behavioral Neuroscience, Departamento de Farmacologia Universidade Federal de São Paulo São Paulo Brazil
2 shared publications - Cássio Morais Loss
Stiles-Nicholson Brain Institute, Charles E. Schmidt College of Medicine, Florida Atlantic University
2 shared publications N.B. Bertagna
Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil
2 shared publicationsP.C. Bianchi
Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Elsevier in Neuroscience
- Vol. 610, 284-296
Hippocampal network engagement in cue plus context-induced ethanol seeking in male mice
- 16 June 2026
- Published by Elsevier in Neuroscience
- Vol. 610, 284-296
Open AccessHippocampal network engagement in cue plus context-induced ethanol seeking in male mice
- Open Access
- 20 February 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19
Editorial: Neurobiological basis of substance use disorders: new findings and perspectives
- 20 February 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19
Open AccessEditorial: Neurobiological basis of substance use disorders: new findings and perspectives
- Open Access
Differential Effects of Cocaine Self-Administration Regimens on Incubation of Cocaine Craving and Nucleus Accumbens Neuronal Ensembles Activated by Cocaine-Associated Context
Drug addiction develops in a subset of users following repeated exposure, influenced by biopsychosocial factors. Rodent self-administration protocols, varying in drug access times, are used to study both controlled and compulsive drug-taking behaviors and their neurobiological underpinnings. Drug-associated cues and environmental contexts are well-established triggers for relapse, with susceptibility to these stimuli peaking during early abstinence and remaining elevated, thereby increasing relapse risk. This phenomenon, known as incubation of craving, has been replicated across substances in animal models. The associative learning between drug effects and contextual cues is encoded by neuronal ensembles activated by drug-associated stimuli, driving craving, seeking, and relapse. Neuronal ensembles in the nucleus accumbens (NAcc) are strongly involved in drug seeking, with parvalbumin-expressing fast-spiking interneurons playing a key role in this associative learning process. We investigated activation patterns in the NAcc triggered by cocaine-related cues following restricted- or extended-access self-administration and examined how forced abstinence alters these patterns, contributing to the incubation of cocaine craving. We also analyzed the engagement of parvalbumin-positive interneurons in NAcc neuronal ensembles before and after forced abstinence. Our findings show that the extended access protocol more effectively induced the incubation of cocaine craving. Neuronal activation in the NAcc core increased after thirty days of forced abstinence in both groups, with extended access rats showing consistently higher activation. Forced abstinence also increased NAcc shell activation, with no differences between protocols. NAcc core activation, but not shell, was influenced by cocaine consumption during training. Notably, extended access rats exhibited reduced parvalbumin interneurons activation following thirty days of forced abstinence. Based on these findings, we speculate that the transition from occasional to compulsive drug-taking may be driven by molecular changes in the NAcc core that enhance its responsiveness to drug-related cues. Additionally, the incubation of craving could be linked to impaired inhibitory control of NAcc core medium spiny neurons by PV interneurons.
Open AccessDifferential Effects of Cocaine Self-Administration Regimens on Incubation of Cocaine Craving and Nucleus Accumbens Neuronal Ensembles Activated by Cocaine-Associated Context
Drug addiction develops in a subset of users following repeated exposure, influenced by biopsychosocial factors. Rodent self-administration protocols, varying in drug access times, are used to study both controlled and compulsive drug-taking behaviors and their neurobiological underpinnings. Drug-associated cues and environmental contexts are well-established triggers for relapse, with susceptibility to these stimuli peaking during early abstinence and remaining elevated, thereby increasing relapse risk. This phenomenon, known as incubation of craving, has been replicated across substances in animal models. The associative learning between drug effects and contextual cues is encoded by neuronal ensembles activated by drug-associated stimuli, driving craving, seeking, and relapse. Neuronal ensembles in the nucleus accumbens (NAcc) are strongly involved in drug seeking, with parvalbumin-expressing fast-spiking interneurons playing a key role in this associative learning process. We investigated activation patterns in the NAcc triggered by cocaine-related cues following restricted- or extended-access self-administration and examined how forced abstinence alters these patterns, contributing to the incubation of cocaine craving. We also analyzed the engagement of parvalbumin-positive interneurons in NAcc neuronal ensembles before and after forced abstinence. Our findings show that the extended access protocol more effectively induced the incubation of cocaine craving. Neuronal activation in the NAcc core increased after thirty days of forced abstinence in both groups, with extended access rats showing consistently higher activation. Forced abstinence also increased NAcc shell activation, with no differences between protocols. NAcc core activation, but not shell, was influenced by cocaine consumption during training. Notably, extended access rats exhibited reduced parvalbumin interneurons activation following thirty days of forced abstinence. Based on these findings, we speculate that the transition from occasional to compulsive drug-taking may be driven by molecular changes in the NAcc core that enhance its responsiveness to drug-related cues. Additionally, the incubation of craving could be linked to impaired inhibitory control of NAcc core medium spiny neurons by PV interneurons.
- 22 November 2024
- Published by Elsevier in Neuroscience
- Vol. 565, 124-137
Impacts of maternal separation stress on ethanol intake and endocannabinoid system in adolescent mice
- 22 November 2024
- Published by Elsevier in Neuroscience
- Vol. 565, 124-137
Impacts of maternal separation stress on ethanol intake and endocannabinoid system in adolescent mice
- 24 October 2024
- Published by Elsevier
- Vol. 178, 355-381
Animal models for studying therapeutic targets and treatments for alcohol use disorder
- 24 October 2024
- Published by Elsevier
- Vol. 178, 355-381
Animal models for studying therapeutic targets and treatments for alcohol use disorder
- 18 October 2024
- Published by Elsevier
- Vol. 178, 1-22
Introduction: Approved treatments for alcohol use disorder by regulatory agencies
- 18 October 2024
- Published by Elsevier
- Vol. 178, 1-22
Introduction: Approved treatments for alcohol use disorder by regulatory agencies
- Open Access
- 1 December 2023
- Published by MDPI AG in Future Pharmacology
- Vol. 3 (4) , 916-925
Evaluations of NSAIDs and Opioids as Analgesics in Pediatric Oncology
As one of the leading causes of death in childhood, cancer also causes discomfort to pediatric patients. Even with guidelines for pain management, more than half of hospitalized children have intense and unrelieved pain. The present work aims to describe the intensity of pain and its pharmacological management in a pediatric oncology population. Patients aged 0 to 17 years old, diagnosed with cancer, who were admitted to a children’s oncology hospital and had well-documented data on pain management in their medical records were included. A total of 333 patients were included, mostly male (55.8%) with a mean age of 7.9 years. A substantial portion of the patient cohort (51.4%) initially reported experiencing pain of moderate intensity during the first assessment. Subsequently, following the pharmacological intervention, a significant proportion of patients (90.1%) reported complete alleviation of pain. The predominant pharmaceutical agents utilized for pain management encompassed metamizole (76.6%) and morphine (10.2%). All pharmacological interventions used were able to significantly reduce patients’ pain. This study underscores the utilization of different pharmacological classes to achieve notable reductions in pain intensity among patients grappling with severe pain.
- 1 December 2023
- Published by MDPI AG in Future Pharmacology
- Vol. 3 (4) , 916-925
Open AccessEvaluations of NSAIDs and Opioids as Analgesics in Pediatric Oncology
As one of the leading causes of death in childhood, cancer also causes discomfort to pediatric patients. Even with guidelines for pain management, more than half of hospitalized children have intense and unrelieved pain. The present work aims to describe the intensity of pain and its pharmacological management in a pediatric oncology population. Patients aged 0 to 17 years old, diagnosed with cancer, who were admitted to a children’s oncology hospital and had well-documented data on pain management in their medical records were included. A total of 333 patients were included, mostly male (55.8%) with a mean age of 7.9 years. A substantial portion of the patient cohort (51.4%) initially reported experiencing pain of moderate intensity during the first assessment. Subsequently, following the pharmacological intervention, a significant proportion of patients (90.1%) reported complete alleviation of pain. The predominant pharmaceutical agents utilized for pain management encompassed metamizole (76.6%) and morphine (10.2%). All pharmacological interventions used were able to significantly reduce patients’ pain. This study underscores the utilization of different pharmacological classes to achieve notable reductions in pain intensity among patients grappling with severe pain.
- 12 May 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 809, 137295
Impacts of maternal separation stress on ethanol-related responses, anxiety- and depressive-like behaviors in adolescent mice
- 12 May 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 809, 137295
Impacts of maternal separation stress on ethanol-related responses, anxiety- and depressive-like behaviors in adolescent mice
- 11 April 2023
- Published by Elsevier in Behavioural Brain Research
- Vol. 448, 114435
Involvement of cortical projections to basolateral amygdala in context-induced reinstatement of ethanol-seeking in rats
- 11 April 2023
- Published by Elsevier in Behavioural Brain Research
- Vol. 448, 114435
Involvement of cortical projections to basolateral amygdala in context-induced reinstatement of ethanol-seeking in rats
- Open Access
- 25 January 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (2) , 234
The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder
Astrocytic-secreted matricellular proteins have been shown to influence various aspects of synaptic function. More recently, they have been found altered in animal models of psychiatric disorders such as drug addiction. Hevin (also known as Sparc-like 1) is a matricellular protein highly expressed in the adult brain that has been implicated in resilience to stress, suggesting a role in motivated behaviors. To address the possible role of hevin in drug addiction, we quantified its expression in human postmortem brains and in animal models of alcohol abuse. Hevin mRNA and protein expression were analyzed in the postmortem human brain of subjects with an antemortem diagnosis of alcohol use disorder (AUD, n = 25) and controls (n = 25). All the studied brain regions (prefrontal cortex, hippocampus, caudate nucleus and cerebellum) in AUD subjects showed an increase in hevin levels either at mRNA or/and protein levels. To test if this alteration was the result of alcohol exposure or indicative of a susceptibility factor to alcohol consumption, mice were exposed to different regimens of intraperitoneal alcohol administration. Hevin protein expression was increased in the nucleus accumbens after withdrawal followed by a ethanol challenge. The role of hevin in AUD was determined using an RNA interference strategy to downregulate hevin expression in nucleus accumbens astrocytes, which led to increased ethanol consumption. Additionally, ethanol challenge after withdrawal increased hevin levels in blood plasma. Altogether, these results support a novel role for hevin in the neurobiology of AUD.
- 25 January 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (2) , 234
Open AccessThe Matricellular Protein Hevin Is Involved in Alcohol Use Disorder
Astrocytic-secreted matricellular proteins have been shown to influence various aspects of synaptic function. More recently, they have been found altered in animal models of psychiatric disorders such as drug addiction. Hevin (also known as Sparc-like 1) is a matricellular protein highly expressed in the adult brain that has been implicated in resilience to stress, suggesting a role in motivated behaviors. To address the possible role of hevin in drug addiction, we quantified its expression in human postmortem brains and in animal models of alcohol abuse. Hevin mRNA and protein expression were analyzed in the postmortem human brain of subjects with an antemortem diagnosis of alcohol use disorder (AUD, n = 25) and controls (n = 25). All the studied brain regions (prefrontal cortex, hippocampus, caudate nucleus and cerebellum) in AUD subjects showed an increase in hevin levels either at mRNA or/and protein levels. To test if this alteration was the result of alcohol exposure or indicative of a susceptibility factor to alcohol consumption, mice were exposed to different regimens of intraperitoneal alcohol administration. Hevin protein expression was increased in the nucleus accumbens after withdrawal followed by a ethanol challenge. The role of hevin in AUD was determined using an RNA interference strategy to downregulate hevin expression in nucleus accumbens astrocytes, which led to increased ethanol consumption. Additionally, ethanol challenge after withdrawal increased hevin levels in blood plasma. Altogether, these results support a novel role for hevin in the neurobiology of AUD.